Abstract
The role of intermediate methylation states in DNA is unclear. Here, to comprehensively identify regions of intermediate methylation and their quantitative relationship with gene activity, we apply integrative and comparative epigenomics to 25 human primary cell and tissue samples. We report 18,452 intermediate methylation regions located near 36% of genes and enriched at enhancers, exons and DNase I hypersensitivity sites. Intermediate methylation regions average 57% methylation, are predominantly allele-independent and are conserved across individuals and between mouse and human, suggesting a conserved function. These regions have an intermediate level of active chromatin marks and their associated genes have intermediate transcriptional activity. Exonic intermediate methylation correlates with exon inclusion at a level between that of fully methylated and unmethylated exons, highlighting gene context-dependent functions. We conclude that intermediate DNA methylation is a conserved signature of gene regulation and exon usage.
Introduction
In the field of epigenetics, DNA methylation—the addition of a methyl group to CpG sites—is traditionally viewed as a binary system. Genomic regions are typically described as either fully methylated, which represses gene activity, or unmethylated, which allows it. However, researchers have long observed "gray areas" where methylation levels hover around 50%.
Until now, it was unclear whether these intermediate states were biological noise, transitionary phases, or a distinct regulatory mechanism. This study seeks to comprehensively map these intermediate methylation (IM) regions and determine their functional significance, distinguishing them from simple genomic imprinting to reveal a complex, population-wide regulatory signature.
Methodology
The researchers employed a "double-check" strategy across 25 human primary cell and tissue samples, including breast, blood, brain, and embryonic stem cells. They integrated two complementary techniques to pinpoint intermediate states with high confidence:
- MeDIP-Seq: Captures methylated DNA using antibodies.
- MRE-Seq: Identifies unmethylated DNA using methylation-sensitive enzymes.
By identifying regions where both signals overlapped, they defined the boundaries of IM regions using a maximum scoring segment algorithm. Findings were validated using high-resolution techniques including Whole Genome Bisulfite Sequencing (WGBS), ChIP-Seq for histone modifications, and RNA-Seq for gene expression and exon inclusion. Comparative epigenomics in mice was also used to assess evolutionary conservation.
Results
Characterizing the Intermediate State
The study identified 18,452 unique autosomal IM regions in humans, located near 36% of all genes. These regions average 57% methylation and correlate with intermediate levels of active chromatin marks (such as H3K4me1/3) and intermediate transcript levels. This suggests that IM functions as a programmed "dimmer switch" for gene activity rather than a simple binary on/off state.
Tissue Specificity and Conservation
While some IM regions are constitutive, the majority are tissue-specific, helping define the identity of different cell types. Analysis showed that approximately 90% of these regions are Allele-Independent Methylation (AIM), suggesting a stable form of epigenetic heterogeneity within cell populations rather than simple imprinting.
Furthermore, the study found a striking relationship between IM and splicing. Fully methylated exons are usually included in transcripts, while unmethylated ones are often skipped; IM exons show an intermediate level of inclusion. Deep conservation was also observed, with nearly 18% of mouse IM regions directly overlapping with human counterparts, implying these regions are essential for mammalian biology.
Discussion
While this research establishes a strong link between IM and gene activity, several questions remain. The study demonstrates correlation, but future work using CRISPR-based epigenetic editing is needed to prove causality. Additionally, the mechanistic origins of how a cell maintains a stable 50% methylation level—whether through dynamic equilibrium or structural properties—remain to be fully elucidated. Finally, while the authors lean toward stable heterogeneity, single-cell sequencing will be necessary to determine if IM represents a uniform "half-methylated" state in every cell or a balanced mixture of states within a population.
Summary updated